Back to funds
View filing
Fairmount Funds Management LLC
hedge fundUpdated 28 days agoManaged by Fairmount Funds Management Llc • Latest filing Q2 2026
Portfolio value
$1.5B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
34.5%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $581.5M |
| Q2 2023 | $709.3M |
| Q3 2023 | $831.2M |
| Q4 2023 | $946.5M |
| Q1 2024 | $917.4M |
| Q2 2024 | $885.1M |
| Q3 2024 | $1.2B |
| Q4 2024 | $1B |
| Q1 2025 | $644.6M |
| Q2 2025 | $771.9M |
| Q3 2025 | $1.1B |
| Q4 2025 | $1.3B |
| Q1 2026 | $1.4B |
| Q2 2026 | $1.5B |
Top holdings
12 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | O ORKA ORUKA THERAPEUTICS INC | $352.6M | 3.71M | 23.31% | — |
| 2 | D DNTH DIANTHUS THERAPEUTICS INC | $247.3M | 2.54M | 16.35% | — |
| 3 | ? N/A DAMORA THERAPEUTICS INC | $226.6M | 8.71M | 14.98% | — |
| 4 | C COGT COGENT BIOSCIENCES INC | $213M | 5.50M | 14.08% | — |
| 5 | J JBIO JADE BIOSCIENCES INC | $101.2M | 4.55M | 6.69% | — |
| 6 | E ELVN ENLIVEN THERAPEUTICS INC | $94.2M | 1.86M | 6.22% | — |
| 7 | V VRDN VIRIDIAN THERAPEUTICS INC | $93.5M | 5.09M | 6.18% | — |
| 8 | Z ZBIO ZENAS BIOPHARMA INC | $59.9M | 2.36M | 3.96% | — |
| 9 | ? N/A CRESCENT BIOPHARMA INC. | $49.5M | 2.75M | 3.27% | — |
| 10 | A APGE APOGEE THERAPEUTICS INC | $39.6M | 298.6K | 2.62% | — |
| 11 | F FTH FAETH THERAPEUTICS INC | $18.1M | 722.0K | 1.19% | — |
| 12 | I IKT INHIBIKASE THERAPEUTICS INC | $17.5M | 8.63M | 1.16% | — |